Skip to Content
Merck
All Photos(1)

Documents

EHU114851

Sigma-Aldrich

MISSION® esiRNA

targeting human MFF

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CAACCATTGAAGGAACGTCAGATGACCTGACTGTTGTAGATGCAGCTTCACTAAGACGACAGATAATCAAACTAAATAGACGTCTACAACTTCTGGAAGAGGAGAACAAAGAACGTGCTAAAAGAGAAATGGTCATGTATTCAATTACTGTAGCTTTCTGGCTGCTTAATAGCTGGCTCTGGTTTCGCCGCTAGAGGTAACATCAGCCCTCAAAAATACTGTCTCAACAGCTGGAAATATAAAAGATTTGCAAACTTCTTTGTTTCTGTCTCTGCATTGTATGCCATTTTATAGTCCACACCCTGAAAATGTATTTCTTCCAGAAAGTCTGGAGGAAGGACCTATATTTGTAGAAGTAAAGGTATATTCTGTCACTCAGCTGTATTCACGTCTGAGCAGTTCTGC

Ensembl | human accession no.

ENSG00000168958

NCBI accession no.

NM_020194

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... MFF(56947) , MFF(56947)

Related Categories

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yi-Tong Lu et al.
Cell death & disease, 9(6), 672-672 (2018-06-06)
Altered mitochondrial metabolism acts as an initial cause for cardiovascular diseases and metabolic intermediate succinate emerges as a mediator of mitochondrial dysfunction. This work aims to investigate whether or not extracellular succinate accumulation and its targeted G protein-coupled receptor-91 (GPR91)
Song Fan et al.
Oncotarget, 6(17), 14885-14904 (2015-04-29)
Cisplatin has been widely employed as a cornerstone chemotherapy treatment for a wide spectrum of solid neoplasms; increasing tumor responsiveness to cisplatin has been a topic of interest for the past 30 years. Strong evidence has indicated that mitochondrial fission

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service